Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4525896
Max Phase: Preclinical
Molecular Formula: C27H33N3O3
Molecular Weight: 447.58
Molecule Type: Unknown
Associated Items:
ID: ALA4525896
Max Phase: Preclinical
Molecular Formula: C27H33N3O3
Molecular Weight: 447.58
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC12C=CC3(CN(Cc4ccccc4)C(=O)C3C1C(=O)N/N=C1\C[C@H]3CC[C@]1(C)C3(C)C)O2
Standard InChI: InChI=1S/C27H33N3O3/c1-24(2)18-10-11-25(24,3)19(14-18)28-29-22(31)20-21-23(32)30(15-17-8-6-5-7-9-17)16-27(21)13-12-26(20,4)33-27/h5-9,12-13,18,20-21H,10-11,14-16H2,1-4H3,(H,29,31)/b28-19+/t18-,20?,21?,25+,26?,27?/m1/s1
Standard InChI Key: UOARUVVXNIQCLT-MIIIGZTISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 447.58 | Molecular Weight (Monoisotopic): 447.2522 | AlogP: 3.68 | #Rotatable Bonds: 4 |
Polar Surface Area: 71.00 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 11.80 | CX Basic pKa: 1.55 | CX LogP: 3.36 | CX LogD: 3.36 |
Aromatic Rings: 1 | Heavy Atoms: 33 | QED Weighted: 0.57 | Np Likeness Score: 0.28 |
1. Kovaleva KS, Zubkov FI, Bormotov NI, Novikov RA, Dorovatovskii PV, Khrustalev VN, Gatilov YV, Zarubaev VV, Yarovaya OI, Shishkina LN, Salakhutdinov NF.. (2018) Synthesis of d-(+)-camphor-based N-acylhydrazones and their antiviral activity., 9 (12): [PMID:30746065] [10.1039/C8MD00442K] |
2. Yarovaya OI, Kovaleva KS, Zaykovskaya AA, Yashina LN, Scherbakova NS, Scherbakov DN, Borisevich SS, Zubkov FI, Antonova AS, Peshkov RY, Eltsov IV, Pyankov OV, Maksyutov RA, Salakhutdinov NF.. (2021) New class of hantaan virus inhibitors based on conjugation of the isoindole fragment to (+)-camphor or (-)-fenchone hydrazonesv., 40 [PMID:33705902] [10.1016/j.bmcl.2021.127926] |
Source(1):